ascendis pharma glp-1 receptor agonist medications GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art Dual and Triple Gut Peptide
Description
The results of the PIONEER-3 trial have now been published in the renowned journal Journal of the American Medical Association (JAMA) and are said to be trend-setting for future therapy of type 2 diabetes.
CBS News medical correspondent Dr
After their success in the obesity field, GLP-1 agonists are gaining interest in addiction treatment
Shima Hadidchi, MD, in Apple Valley and Victorville, CA
Glucagon-like peptide-1 receptor agonists, namely GLP-1 receptor agonists, are a class of drugs for the treatment of type 2 diabetes.
Their findings suggest that patients may be able to continue taking the medications prior to their surgeries without a high risk of aspiration.As more patients begin taking medications to help manage blood sugar l
